|
|
 |
|
Viewing report
|
|
|
|
The Pharmaceutical Licensing Outlook: A Strategic Guide To Effective Deal-Making And Profitable Partnerships
Business Insights, Aug 2002
Several factors have combined to transform the role of licensing in the pharmaceutical industry - the reconfiguration of the value chain, ongoing global consolidation and M&A and plummeting R&D productivity.
In response, licensing has moved away from its roots as a transaction for intellectual property rights, emerging as a key value driver.
Industry leaders now recognise licensing as a strategic mechanism through which they can achieve their corporate objectives.
The Pharmaceutical Licensing Outlook identifies and examines current best practice in licensing.
Using a blend of market analysis, case studies and executive interviews, the author provides a comprehensive guide to how best to maximize the returns on licensing activity.
Equally valuable for pharmaceutical companies, biotechnology companies and technology providers, this groundbreaking report offers both practical and strategic analysis, including a detailed evaluation of successful deal-making.
Customers who bought this item also bought
Licensing Strategies - Examining Today’s Pharmaceutical Licensing Trends
Pharmaceutical Licensing Strategies: Best Practices in Deal-Making, Valuations and Strategic Management
Evolving Trends in Biopharmaceutical Licensing: Deal Assessments, Drivers and Resistors
Licensing Strategies: Trends In The Top 20 Pharmaceutical Companies Activity
Effective Licensing & Commercialisation of Drug Delivery Systems 2006
Biotechnology Licensing: How Has the Balance of Power Shifted?
Licensing Strategies: Benchmarking Analysis of the Top 20 Pharmaceutical Companies
Evolving Trends in Licensing: Strategies for Building and Retaining Value in Biotechnology Alliances
Optimizing Licensing Strategies for the 21st Century: Creating Win-Win Pharmaceutical and Biotech Licensing Deals
Bio-Device Licensing: Strategies for Success
The Survey of Library Database Licensing Practices
Valuing and Structuring Pharmaceutical Licensing Agreements
|
|
|
|
